Back
Xenon Pharmaceuticals 10K Form
Buy
61
XENE
Xenon Pharmaceuticals
Last Price:
41.21
Seasonality Move:
29.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
| 2023-11-08 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
| 2023-08-09 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
| 2023-05-09 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
| 2022-11-08 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
| 2022-08-09 | 10Q | XENE/Xenon Pharmaceuticals Quarterly |
Receive XENE News And Ratings
See the #1 stock for the next 7 days that we like better than XENE
XENE Financial Statistics
Sales & Book Value
| Annual Sales: | $9.43M |
|---|---|
| Cash Flow: | $-51.74M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.53 |
| Price / Book: | 3.93 |
Profitability
| EPS (TTM): | -2.82000 |
|---|---|
| Net Income (TTM): | $-213.39M |
| Gross Margin: | $6.83M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Xenon Pharmaceuticals Earnings Forecast
Key Xenon Pharmaceuticals Financial Ratios
Xenon Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XENE |
| CUSIP: | 98420N |
| Website: | xenon-pharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XENE Technical Analysis vs Fundamental Analysis
Buy
61
Xenon Pharmaceuticals (XENE)
is a Buy
Is Xenon Pharmaceuticals a Buy or a Sell?
-
Xenon Pharmaceuticals stock is rated a Buy
The current Xenon Pharmaceuticals [XENE] share price is $41.15. The Score for XENE is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.